Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05398627Not ApplicableCompleted

Neurofeedback for Borderline Personality Disorder

Role: lead

NCT03428828Not ApplicableCompleted

Neurofeedback for Treatment Resistant Depression

Role: lead

NCT05703256Not ApplicableRecruiting

Amygdala Neurofeedback for Depression - Large Scale Clinical Trial

Role: lead

NCT02709161Not ApplicableTerminated

Effects of Amygdala Neurofeedback on Depressive Symptoms

Role: lead

All 4 trials loaded